Finanzielle Vergleiche Lonza Group AG

Aktien

928619

CH0013841017

LONN

Biotechnologie

Realtime-Estimate Cboe Europe 12:24:14 19.02.2025 % 5 Tage % 1. Jan.
585.30 CHF -0.02% Intraday Chart für Lonza Group AG -2.34% +9.11%
Hauptkonkurrenten
Zu einer Liste hinzufügen
Umsatz (Y-1) Nettogewinn (Y-1) EBIT-Marge (Y-1) ROE (Y-1) ROA (Y-1) Verschuldungsgrad (Y-1)
7.98 Mrd. 9.74%13.98%6.52%3.82%0.46x
15.4 Mrd. 8.91%20.12%22.55%5.12%3.33x
1.68 Mrd. 24.61%29.93%5.07%4.31%1.46x
2.33 Mrd. 42.31%50.91%18.27%14.91%-1.85x
8.12 Mrd. 7.54%19.31%6.9%3.58%2x
532 Mio. 40.26% - - - -
6.85 Mrd. 68.84%61.9%28.59%21.29%2.38x
1.16 Mrd. 14.5%31.94%14.11%6.29%0.4x
2.11 Mrd. 19.17%21.38%45.7%19.42%-0.58x
1.97 Mrd. 17.37%26.9%4.69%2.75%0.69x
4.13 Mrd. 11.49%20.31%16.7%6.95%2.34x
11.58 Mio. 3’768.28%4’207.12%34.76%30.38%3.85x
1.63 Mrd. 13.88%14.92%13.86%6.82%1.36x
1.04 Mrd. 27.44%35.35%9.95%7.09%-1.51x
509 Mio. 13.19%41.67%31.26%21.6%-0.14x
343 Mio. 1.04%10.29%34.35%12.03%-1.95x
1.56 Mrd. 23.57%27%30.95%18.86%-0.61x
788 Mio. 46.45%44.8%76.34%13.26%3.21x
686 Mio. 19.38%22.41%9% - -1.79x
Durchschnitt 3.1 Mrd. -194.53% -222.82% 3.76% 1.5% 0.73x
Gewichteter Durchschnitt nach Marktkapitalisierung 5.31 Mrd. -109.12% -120.78% 7.36% 2.84% 1.05x
Biotechnologie und medizinische Forschung - Andere